News
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Pfizer Inc. and BioNTech SE announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development program, Project Lightspeed, against SARS-CoV-2, were published online in the journal Nature. These preliminary clinical data on BNT162b1, a nucleoside-modified messenger RNA (modRNA)...
News
Gilead Submits New Drug Application to U.S. FDA for Veklury for the Treatment of COVID-19
Gilead Sciences, Inc. announced that it has submitted a New Drug Application (NDA) to the U.S. FDA for Veklury® (remdesivir), an investigational antiviral for the treatment of patients with COVID-19. Veklury is currently available in the U.S. under an...
News
Novavax Inc and Serum Institute of India Announce Development and Commercial Collaboration
Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced a license agreement with Serum Institute of India Private Limited (SIIPL) for the development and commercialization of NVX CoV2373, Novavax’ COVID?19 vaccine candidate, in low-...
News
Innovent and Eli Lilly Announce Acceptance of a Supplemental NDA of TYVYT in Platinum as First-Line Therapy in Non-Small Cell Lung Cancer in China
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, jointly announced with Eli Lilly and Company that the National Medical Products Administration...
News
Evotec receives CARB-X funding for Resolutes antibiotic project
Evotec SE announced that the Company has entered into a new partnership with the Biotech company Resolute Therapeutics to combat infectious diseases and antimicrobial resistance. The partnership aims to develop a broad-spectrum antibiotic with a new mode of action...
News
WuXi Vaccines Appoints Mr. Jian Dong as Chief Executive Officer
WuXi Vaccines, a global leading company with world-class vaccine contract development and manufacturing organization (CDMO) capabilities, is pleased to announce the appointment of Mr. Jian Dong as Chief Executive Officer (CEO). WuXi Vaccines is a joint venture established between...
News
Bayer to acquire UK-based biotech KaNDy Therapeutics Ltd
Bayer, a global leader in women’s healthcare, and KaNDy Therapeutics Ltd, a UK clinical-stage biotech company, announced that Bayer will acquire KaNDy Therapeutics Ltd. to expand its drug development pipeline in women’s healthcare. KaNDy Therapeutics Ltd. recently completed the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.